Marc Tessier-Lavigne
Affiliations
- Director at Denali Therapeutics Inc. (DNLI), 2025-06-05
- Director at Regeneron Pharmaceuticals Inc. (REGN), 2023-01-05
- Director at Agios Pharmaceuticals Inc (AGIO), 2016-06-23
- Director at Juno Therapeutics Inc. (JUNO), 2016-06-21
- Director at Pfizer Inc (PFE), 2015-04-24
- Officer at Genentech Inc (DNA), 2009-03-30
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| AGIO | $18.00 | 55,555 | $999,990.00 | 101,009 | 2013-07-24 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| DNLI | $30.48 | 20,000 | $609,600.00 | 1,870,356 | 2022-11-23 | Filing |
| DNLI | $30.33 | 11,252 | $341,273.16 | 1,890,356 | 2022-11-02 | Filing |
| DNLI | $30.20 | 8,748 | $264,189.60 | 1,901,608 | 2022-11-01 | Filing |
| REGN | $718.00 | 3,612 | $2,593,416.00 | 2,269 | 2022-10-03 | Filing |
| REGN | $698.00 | 3,428 | $2,392,744.00 | 2,269 | 2022-09-30 | Filing |